Table of Contents Malignant Mesothelioma Drugs Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025 1 Industry Overview of Malignant Mesothelioma Drugs 1.1 Malignant Mesothelioma Drugs Market Overview 1.1.1 Malignant Mesothelioma Drugs Product Scope 1.1.2 Market Status and Outlook 1.2 Global Malignant Mesothelioma Drugs Market Size and Analysis by Regions 1.2.1 North America 1.2.2 Europe 1.2.3 China 1.2.4 Rest of Asia Pacific 1.2.5 Central & South America 1.2.6 Middle East & Africa 1.3 Malignant Mesothelioma Drugs Market by Type 1.3.1 Global Malignant Mesothelioma Drugs Revenue (Million US$) and Growth Comparison by Type (2014-2025) 1.3.2 Global Malignant Mesothelioma Drugs Revenue Market Share by Type in 2018 1.3.3 Pemetrexed 1.3.4 Cisplatin 1.3.5 Carboplatin 1.3.6 Gemcitabine 1.3.7 Vinorelbine 1.3.8 Other 1.4 Malignant Mesothelioma Drugs Market by End Users/Application 1.4.1 Hospital Pharmacies 1.4.2 Retail Pharmacies 1.4.3 Oncology Centers 1.4.4 Other 2 Global Malignant Mesothelioma Drugs Competition Analysis by Players 2.1 Global Malignant Mesothelioma Drugs Market Size (Million US$) by Players (2014-2019) 2.2 Competitive Status 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 Mergers & Acquisitions, Expansion Plans 3 Company (Top Players) Profiles and Key Data 3.1 AstraZeneca 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Malignant Mesothelioma Drugs Revenue (Value) (2014-2019) 3.1.5 Recent Developments 3.2 Bristol-Myers Squibb 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Malignant Mesothelioma Drugs Revenue (Value) (2014-2019) 3.2.5 Recent Developments 3.3 Roche 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Malignant Mesothelioma Drugs Revenue (Value) (2014-2019) 3.3.5 Recent Developments 3.4 Merck 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Malignant Mesothelioma Drugs Revenue (Value) (2014-2019) 3.4.5 Recent Developments 3.5 Novartis 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Malignant Mesothelioma Drugs Revenue (Value) (2014-2019) 3.5.5 Recent Developments 3.6 Pfizer 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Malignant Mesothelioma Drugs Revenue (Value) (2014-2019) 3.6.5 Recent Developments 3.7 Sanofi 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Malignant Mesothelioma Drugs Revenue (Value) (2014-2019) 3.7.5 Recent Developments 3.8 Eli Lilly 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Malignant Mesothelioma Drugs Revenue (Value) (2014-2019) 3.8.5 Recent Developments 3.9 Teva Pharmaceuticals 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Malignant Mesothelioma Drugs Revenue (Value) (2014-2019) 3.9.5 Recent Developments 3.10 Boehringer Ingelheim GmbH 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Malignant Mesothelioma Drugs Revenue (Value) (2014-2019) 3.10.5 Recent Developments 3.11 Mylan 3.12 Fresenius Kabi 3.13 Sun Pharmaceuticals 3.14 Corden Pharma 3.15 Concordia International 3.16 Kyowa Hakko Kirin 3.17 Polaris Pharmaceuticals 3.18 MolMed 3.19 Ono Pharmaceutical 3.20 Nichi-Iko Pharmaceutical 4 Global Malignant Mesothelioma Drugs Market Size by Type and Application (2014-2019) 4.1 Global Malignant Mesothelioma Drugs Market Size by Type (2014-2019) 4.2 Global Malignant Mesothelioma Drugs Market Size by Application (2014-2019) 4.3 Potential Application of Malignant Mesothelioma Drugs in Future 4.4 Top Consumer/End Users of Malignant Mesothelioma Drugs 5 North America Malignant Mesothelioma Drugs Development Status and Outlook 5.1 North America Malignant Mesothelioma Drugs Market Size (2014-2019) 5.2 North America Malignant Mesothelioma Drugs Market Size and Market Share by Players (2014-2019) 5.3 North America Malignant Mesothelioma Drugs Market Size by Application (2014-2019) 6 Europe Malignant Mesothelioma Drugs Development Status and Outlook 6.1 Europe Malignant Mesothelioma Drugs Market Size (2014-2019) 6.2 Europe Malignant Mesothelioma Drugs Market Size and Market Share by Players (2014-2019) 6.3 Europe Malignant Mesothelioma Drugs Market Size by Application (2014-2019) 7 China Malignant Mesothelioma Drugs Development Status and Outlook 7.1 China Malignant Mesothelioma Drugs Market Size (2014-2019) 7.2 China Malignant Mesothelioma Drugs Market Size and Market Share by Players (2014-2019) 7.3 China Malignant Mesothelioma Drugs Market Size by Application (2014-2019) 8 Rest of Asia Pacific Malignant Mesothelioma Drugs Development Status and Outlook 8.1 Rest of Asia Pacific Malignant Mesothelioma Drugs Market Size (2014-2019) 8.2 Rest of Asia Pacific Malignant Mesothelioma Drugs Market Size and Market Share by Players (2014-2019) 8.3 Rest of Asia Pacific Malignant Mesothelioma Drugs Market Size by Application (2014-2019) 9 Central & South America Malignant Mesothelioma Drugs Development Status and Outlook 9.1 Central & South America Malignant Mesothelioma Drugs Market Size (2014-2019) 9.2 Central & South America Malignant Mesothelioma Drugs Market Size and Market Share by Players (2014-2019) 9.3 Central & South America Malignant Mesothelioma Drugs Market Size by Application (2014-2019) 10 Middle East & Africa Malignant Mesothelioma Drugs Development Status and Outlook 10.1 Middle East & Africa Malignant Mesothelioma Drugs Market Size (2014-2019) 10.2 Middle East & Africa Malignant Mesothelioma Drugs Market Size and Market Share by Players (2014-2019) 10.3 Middle East & Africa Malignant Mesothelioma Drugs Market Size by Application (2014-2019) 11 Market Forecast by Regions and Application (2019-2025) 11.1 Global Malignant Mesothelioma Drugs Market Size by Regions (2019-2025) 11.1.1 North America Malignant Mesothelioma Drugs Revenue and Growth Rate (2019-2025) 11.1.2 Europe Malignant Mesothelioma Drugs Revenue and Growth Rate (2019-2025) 11.1.3 China Malignant Mesothelioma Drugs Revenue and Growth Rate (2019-2025) 11.1.4 Rest of Asia Pacific Malignant Mesothelioma Drugs Revenue and Growth Rate (2019-2025) 11.1.5 Central & South America Malignant Mesothelioma Drugs Revenue and Growth Rate (2019-2025) 11.1.6 Middle East & Africa Malignant Mesothelioma Drugs Revenue and Growth Rate (2019-2025) 11.2 Global Malignant Mesothelioma Drugs Market Size by Application (2019-2025) 11.3 The Market Drivers in Future 12 Malignant Mesothelioma Drugs Market Dynamics 12.1 Industry Trends 12.2 Market Drivers 12.3 Market Challenges 12.4 Porter’s Five Forces Analysis 13 Research Finding /Conclusion 14 Methodology and Data Source 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer 14.4 Author List

List of Tables and Figures Figure Global Malignant Mesothelioma Drugs Market Size (Million USD) Status and Outlook (2014-2025) Table Global Malignant Mesothelioma Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2025) Figure Global Malignant Mesothelioma Drugs Market Share by Regions (2014-2019) Figure North America Malignant Mesothelioma Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Europe Malignant Mesothelioma Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure China Malignant Mesothelioma Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Rest of Asia Pacific Malignant Mesothelioma Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Central & South America Malignant Mesothelioma Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Middle East & Africa Malignant Mesothelioma Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Global Malignant Mesothelioma Drugs Market Share by Type in 2018 & 2025 Figure Pemetrexed Market Size (Million USD) and Growth Rate (2014-2019) Figure Cisplatin Market Size (Million USD) and Growth Rate (2014-2019) Figure Carboplatin Market Size (Million USD) and Growth Rate (2014-2019) Figure Gemcitabine Market Size (Million USD) and Growth Rate (2014-2019) Figure Vinorelbine Market Size (Million USD) and Growth Rate (2014-2019) Figure Other Market Size (Million USD) and Growth Rate (2014-2019) Table Global Malignant Mesothelioma Drugs Market Size (Million US$) Comparison by Application (2014-2025) Figure Global Malignant Mesothelioma Drugs Market Share by Application in 2018 & 2025 Figure Malignant Mesothelioma Drugs Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2014-2019) Figure Malignant Mesothelioma Drugs Market Size (Million USD) and Growth Rate in Retail Pharmacies (2014-2019) Figure Malignant Mesothelioma Drugs Market Size (Million USD) and Growth Rate in Oncology Centers (2014-2019) Figure Malignant Mesothelioma Drugs Market Size (Million USD) and Growth Rate in Other (2014-2019) Table Global Malignant Mesothelioma Drugs Revenue (Million US$) by Players (2014-2019) Table Global Malignant Mesothelioma Drugs Revenue Market Share by Players (2014-2019) Eigure Malignant Mesothelioma Drugs Market Size Share by Players in 2018 Table Global Malignant Mesothelioma Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Global Top 5 Players Malignant Mesothelioma Drugs Market Share in 2018 Figure Global Top 10 Players Malignant Mesothelioma Drugs Market Share in 2018 Table Malignant Mesothelioma Drugs Key Players Product/Service Table Mergers & Acquisitions, Expansion Plans Table AstraZeneca Basic Information List Table AstraZeneca Description and Business Overview Table AstraZeneca Malignant Mesothelioma Drugs Products, Services and Solutions Table Revenue (Million US$) in Malignant Mesothelioma Drugs Business of AstraZeneca (2014-2019) Table AstraZeneca Malignant Mesothelioma Drugs Recent Developments Table Bristol-Myers Squibb Basic Information List Table Bristol-Myers Squibb Description and Business Overview Table Bristol-Myers Squibb Malignant Mesothelioma Drugs Products, Services and Solutions Table Revenue (Million US$) in Malignant Mesothelioma Drugs Business of Bristol-Myers Squibb (2014-2019) Table Bristol-Myers Squibb Malignant Mesothelioma Drugs Recent Developments Table Roche Basic Information List Table Roche Description and Business Overview Table Roche Malignant Mesothelioma Drugs Products, Services and Solutions Table Revenue (Million US$) in Malignant Mesothelioma Drugs Business of Roche (2014-2019) Table Roche Malignant Mesothelioma Drugs Recent Developments Table Merck Basic Information List Table Merck Description and Business Overview Table Merck Malignant Mesothelioma Drugs Products, Services and Solutions Table Revenue (Million US$) in Malignant Mesothelioma Drugs Business of Merck (2014-2019) Table Merck Malignant Mesothelioma Drugs Recent Developments Table Novartis Basic Information List Table Novartis Description and Business Overview Table Novartis Malignant Mesothelioma Drugs Products, Services and Solutions Table Revenue (Million US$) in Malignant Mesothelioma Drugs Business of Novartis (2014-2019) Table Novartis Malignant Mesothelioma Drugs Recent Developments Table Pfizer Basic Information List Table Pfizer Description and Business Overview Table Pfizer Malignant Mesothelioma Drugs Products, Services and Solutions Table Revenue (Million US$) in Malignant Mesothelioma Drugs Business of Pfizer (2014-2019) Table Pfizer Malignant Mesothelioma Drugs Recent Developments Table Sanofi Basic Information List Table Sanofi Description and Business Overview Table Sanofi Malignant Mesothelioma Drugs Products, Services and Solutions Table Revenue (Million US$) in Malignant Mesothelioma Drugs Business of Sanofi (2014-2019) Table Sanofi Malignant Mesothelioma Drugs Recent Developments Table Eli Lilly Basic Information List Table Eli Lilly Description and Business Overview Table Eli Lilly Malignant Mesothelioma Drugs Products, Services and Solutions Table Revenue (Million US$) in Malignant Mesothelioma Drugs Business of Eli Lilly (2014-2019) Table Eli Lilly Malignant Mesothelioma Drugs Recent Developments Table Teva Pharmaceuticals Basic Information List Table Teva Pharmaceuticals Description and Business Overview Table Teva Pharmaceuticals Malignant Mesothelioma Drugs Products, Services and Solutions Table Revenue (Million US$) in Malignant Mesothelioma Drugs Business of Teva Pharmaceuticals (2014-2019) Table Teva Pharmaceuticals Malignant Mesothelioma Drugs Recent Developments Table Boehringer Ingelheim GmbH Basic Information List Table Boehringer Ingelheim GmbH Description and Business Overview Table Boehringer Ingelheim GmbH Malignant Mesothelioma Drugs Products, Services and Solutions Table Revenue (Million US$) in Malignant Mesothelioma Drugs Business of Boehringer Ingelheim GmbH (2014-2019) Table Boehringer Ingelheim GmbH Malignant Mesothelioma Drugs Recent Developments Table Mylan Basic Information List Table Fresenius Kabi Basic Information List Table Sun Pharmaceuticals Basic Information List Table Corden Pharma Basic Information List Table Concordia International Basic Information List Table Kyowa Hakko Kirin Basic Information List Table Polaris Pharmaceuticals Basic Information List Table MolMed Basic Information List Table Ono Pharmaceutical Basic Information List Table Nichi-Iko Pharmaceutical Basic Information List Table Global Malignant Mesothelioma Drugs Market Size by Type (2014-2019) (Million US$) Figure Global Malignant Mesothelioma Drugs Revenue Market Share by Type in 2018 Table Global Malignant Mesothelioma Drugs Market Size by Application (2014-2019) (Million US$) Figure Global Malignant Mesothelioma Drugs Revenue Market by Application in 2018 Table Top Consumer/End Users of Malignant Mesothelioma Drugs Figure North America Malignant Mesothelioma Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table North America Malignant Mesothelioma Drugs Market Size by Players (2014-2019)(Million US$) Figure North America Malignant Mesothelioma Drugs Market Size Share by Players in 2018 Table North America Malignant Mesothelioma Drugs Market Size by Application (2014-2019) (Million US$) Figure North America Malignant Mesothelioma Drugs Revenue Market Share by Application (2014-2019) Figure North America Malignant Mesothelioma Drugs Market Size Share by Application in 2018 Figure Europe Malignant Mesothelioma Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table Europe Malignant Mesothelioma Drugs Market Size by Players (2014-2019)(Million US$) Figure Europe Malignant Mesothelioma Drugs Market Size Share by Players in 2018 Table Europe Malignant Mesothelioma Drugs Market Size by Application (2014-2019) (Million US$) Figure Europe Malignant Mesothelioma Drugs Revenue Market Share by Application (2014-2019) Figure Europe Malignant Mesothelioma Drugs Market Size Share by Application in 2018 Figure China Malignant Mesothelioma Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table China Malignant Mesothelioma Drugs Market Size by Players (2014-2019)(Million US$) Figure China Malignant Mesothelioma Drugs Market Size Share by Players in 2018 Table China Malignant Mesothelioma Drugs Market Size by Application (2014-2019) (Million US$) Figure China Malignant Mesothelioma Drugs Revenue Market Share by Application (2014-2019) Figure China Malignant Mesothelioma Drugs Market Size Share by Application in 2018 Figure Rest of Asia Pacific Malignant Mesothelioma Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table Rest of Asia Pacific Malignant Mesothelioma Drugs Market Size by Players (2014-2019)(Million US$) Figure Rest of Asia Pacific Malignant Mesothelioma Drugs Market Size Share by Players in 2018 Table Rest of Asia Pacific Malignant Mesothelioma Drugs Market Size by Application (2014-2019) (Million US$) Figure Rest of Asia Pacific Malignant Mesothelioma Drugs Revenue Market Share by Application (2014-2019) Figure Rest of Asia Pacific Malignant Mesothelioma Drugs Market Size Share by Application in 2018 Figure Central & South America Malignant Mesothelioma Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table Central & South America Malignant Mesothelioma Drugs Market Size by Players (2014-2019)(Million US$) Figure Central & South America Malignant Mesothelioma Drugs Market Size Share by Players in 2018 Table Central & South America Malignant Mesothelioma Drugs Market Size by Application (2014-2019) (Million US$) Figure Central & South America Malignant Mesothelioma Drugs Revenue Market Share by Application (2014-2019) Figure Central & South America Malignant Mesothelioma Drugs Market Size Share by Application in 2018 Figure Middle East & Africa Malignant Mesothelioma Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table Middle East & Africa Malignant Mesothelioma Drugs Market Size by Players (2014-2019)(Million US$) Figure Middle East & Africa Malignant Mesothelioma Drugs Market Size Share by Players in 2018 Table Middle East & Africa Malignant Mesothelioma Drugs Market Size by Application (2014-2019) (Million US$) Figure Middle East & Africa Malignant Mesothelioma Drugs Revenue Market Share by Application (2014-2019) Figure Middle East & Africa Malignant Mesothelioma Drugs Market Size Share by Application in 2018 Figure Global Malignant Mesothelioma Drugs Market Size and Growth Rate (Value) (2019-2025) (Million US$) Table Global Malignant Mesothelioma Drugs Market Size by Regions (2019-2025) (Million US$) Figure Global Malignant Mesothelioma Drugs Market Size Share by Regions (2019-2025) Figure Global Malignant Mesothelioma Drugs Market Size Share by Regions in 2025 Figure North America Malignant Mesothelioma Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure Europe Malignant Mesothelioma Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure China Malignant Mesothelioma Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure Rest of Asia Pacific Malignant Mesothelioma Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure Central & South America Malignant Mesothelioma Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure Middle East & Africa Malignant Mesothelioma Drugs Revenue (Million USD) and Growth Rate (2019-2025) Table Global Malignant Mesothelioma Drugs Market Size by Application (2019-2025) (Million USD) Figure Global Malignant Mesothelioma Drugs Market Size by Application (2019-2025) Figure Global Malignant Mesothelioma Drugs Market Size by Application in 2025 Table Global Malignant Mesothelioma Drugs Market Size by Type (2019-2025) (Million US$) Figure Global Malignant Mesothelioma Drugs Market Size by Type (2019-2025) Figure Global Malignant Mesothelioma Drugs Market Size by Type in 2025 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure Porter's Five Forces Analysis Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

AstraZeneca Bristol-Myers Squibb Roche Merck Novartis Pfizer Sanofi Eli Lilly Teva Pharmaceuticals Boehringer Ingelheim GmbH Mylan Fresenius Kabi Sun Pharmaceuticals Corden Pharma Concordia International Kyowa Hakko Kirin Polaris Pharmaceuticals MolMed Ono Pharmaceutical Nichi-Iko Pharmaceutical